Calcineurin Inhibitor-free Immunosuppression Using Everolimus (Certican) after Heart Transplantation: 2 years' Follow-up from the University Hospital Münster-Reference-Cited by-同舟云学术

Calcineurin Inhibitor-free Immunosuppression Using Everolimus (Certican) after Heart Transplantation: 2 years' Follow-up from the University Hospital Münster

Published:2011-06 Issue:5 Volume:43 Page:1847-1852
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Stypmann J.,Engelen M.A.,Eckernkemper S.,Amler S.,Gunia S.,Sindermann J.R.,Rothenburger M.,Rukosujew A.,Drees G.,Welp H.A.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference26 articles.

1. Calcineurin inhibitors in heart transplantation;Keogh;J Heart Lung Transplant,2004

2. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs;Lindenfeld;Circulation,2004

3. Everolimus;Chapman;Drugs,2004

4. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients;Eisen;N Engl J Med,2003

5. Outcomes following de novo CNI-free immunosuppression after heart transplantation: a single-center experience;Leet;Am J Transplant,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Immunosuppression in Solid Organ Transplantation;Pharmacology of Immunosuppression;2022

2. Kidney Disease After Nonkidney Solid Organ Transplant;Advances in Chronic Kidney Disease;2021-11

3. Long‐term experience using CNI‐free immunosuppression in selected paediatric heart transplant recipients;Pediatric Transplantation;2021-08-18

4. Drug-induced gingival overgrowth in cardiovascular patients;World Journal of Cardiology;2021-04-26

5. THE INDIVIDUAL TAILORING OF IMMUNOSUPPRESSIVE THERAPY AFTER HEART TRANSPLANTATION;Russian Journal of Transplantology and Artificial Organs;2018-04-24